ABI1 and prostate carcinoma: Interestingly, this is inconsistent with the earlier discussed role of ABI1 as a tumor suppressor in prostate cancer, in which decreased expression leads to decreased E-cadherin expression and inhibition of canonical WNT signaling [125].